In recent decades, the world has faced several viral outbreaks. But it was SARS-CoV-2, the virus behind COVID-19, that made it clear just how deeply viruses can affect our health, society, and economy. The pandemic brought virology back into sharp focus for researchers and the public alike.

Today, virology research works to understand viruses to develop better diagnostic tests, antiviral drugs, and vaccines. Microplate-based assays and plate readers have become key tools in this process. They give researchers the flexibility to run different types of tests, collect reliable and reproducible data, and track viral infection in real time.
This eBook looks at the microplate-based assays currently used in virology, the new insights they’re generating, and the impact they’re having on the field.
Get your copy of the eBook today to read on!

About BMG LABTECH GmbH
BMG LABTECH has been committed to producing microplate readers for more than twenty years. By focusing on the needs of the scientific community, the company’s innovative microplate readers have earned the company the reputation of being a technology leader in the field.
BMG LABTECH has developed a wide range of dedicated and multi-mode microplate readers for life sciences applications and high-throughput screening.
All BMG LABTECH microplate readers are "Made in Germany" and are conceived, developed, assembled, and tested entirely at our headquarters in Germany.
Since our establishment in Offenburg, Germany in 1989, BMG LABTECH has expanded to offer a worldwide sales and support network with offices in the USA, UK, Australia, Japan and France. Our subsidiaries, regional offices and distributors are committed to bringing you innovative microplate reader technology with the quality and reliability you expect from a German company.
Our staff includes engineers and scientists from the fields of biology, biochemistry, analytical chemistry, and physics.
Sponsored Content Policy: News-Medical.net publishes articles and related content that may be derived from sources where we have existing commercial relationships, provided such content adds value to the core editorial ethos of News-Medical.Net which is to educate and inform site visitors interested in medical research, science, medical devices and treatments.